{"id":203259,"name":"INVITAE INC.","slug":"invitae-inc","state":"CA","country":"United States of America","description":"Company that provides clinical genetic testing services.","totalSpending":1780500,"filings":26,"yearlySpending":[{"year":2019,"income":175500},{"year":2020,"income":245000},{"year":2021,"income":320000},{"year":2022,"income":540000},{"year":2023,"income":360000},{"year":2024,"income":140000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"CPT","display":"Copyright/Patent/Trademark"},{"code":"CSP","display":"Consumer Issues/Safety/Products"}],"firms":["IPOLICY SOLUTIONS"],"lobbyists":["JENNIFER LEIB","MEGAN ANDERSON BROOKS","JAY QIU","LINDSEY TRISCHLER"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Centers For Disease Control & Prevention (CDC)","Veterans Affairs, Dept of (VA)","Office of Science & Technology Policy (OSTP)","Food & Drug Administration (FDA)","Natl Institutes of Health (NIH)","Agency for Healthcare Research & Quality (AHRQ)","Federal Trade Commission (FTC)"],"sampleDescriptions":["Coverage and reimbursement of molecular diagnostics\nNo bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act","Coverage and reimbursement of molecular diagnostics\nNo bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act","No bill #, Labor, HHS, Education and Related Agencies Appropriations FY20","No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act","Medicare coverage of next generation sequencing based tests for cancer"]}